Dr. James J. Lyons, M.D.
Heart Failure & Transplant Cardiology (Advanced Heart Failure and Transplant Cardiology Physician)
- Medicare participating
At a glance
- Medical school
- Georgetown University School of Medicine (1999)
- Years since graduation
- 27
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 2,194
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1999Medical school: Georgetown University School of Medicine
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Advanced Heart Failure and Transplant Cardiology Physician primary
NY license 260442 -
Cardiovascular Disease Physician
NY license 260442 -
Nuclear Cardiology Physician
NY license 260442
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Map: Heart Failure & Transplant Cardiology per capita by county →
Where they work
Hospitals
- Vassar Brothers Medical Center Poughkeepsie, NY
- Northern Dutchess Hospital Rhinebeck, NY
- Sharon Hospital Sharon, CT
Medical groups
- Hudson Valley Cardiovascular Practice PC (70 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 2,194
- Services billed
- 5,172
- Patients’ average age
- 77
| Service | Times | Patients |
|---|---|---|
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 2,005 | 1,491 |
| Established patient office or other outpatient visit, 30-39 minutes | 756 | 386 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 398 | 394 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 369 | 274 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 309 | 124 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 295 | 168 |
| Blood test, clotting time | 228 | 78 |
| Anticoagulant management of patient taking warfarin | 206 | 69 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 163 | 161 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 116 | 115 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Atorvastatin Calcium Other prescribers in Poughkeepsie, NY | 417 |
| Metoprolol Succinate Other prescribers in Poughkeepsie, NY | 339 |
| Furosemide Other prescribers in Poughkeepsie, NY | 329 |
| Eliquis (apixaban) Other prescribers in Poughkeepsie, NY | 329 |
| Carvedilol Other prescribers in Poughkeepsie, NY | 282 |
| Spironolactone Other prescribers in Poughkeepsie, NY | 245 |
| Entresto (sacubitril/valsartan) Other prescribers in Poughkeepsie, NY | 229 |
| Farxiga (dapagliflozin propanediol) Other prescribers in Poughkeepsie, NY | 228 |
| Amlodipine Besylate Other prescribers in Poughkeepsie, NY | 207 |
| Lisinopril Other prescribers in Poughkeepsie, NY | 136 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 6 companies reported 15 payments worth $399 in total to this clinician.
| Abbott Laboratories | $205 |
|---|---|
| Bridgebio Pharma, Inc. | $60.71 |
| Zoll Services LLC (a/k/a Zoll Lifecor Corp) | $44.74 |
| Impulse Dynamics (USA) Inc. | $31.89 |
| E.r. Squibb & Sons, L.l.c. | $29.67 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $26.26 |
| Food and Beverage | $399 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 5 industry-funded studies in 2025, from 5 companies. The companies reported $111,151 in research payments for these studies, mostly to the institutions running them.
- ALLEVIATE-HF
Medtronic, Inc. - A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Maridebart Cafraglutide on Mortality and Morbidity in Participants Living With Heart Failure With Preserved or Mildly…
Amgen Inc. - Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Procyrion, Inc. · Recruiting · NCT05677100 - Assessment of CCM in HF With Higher Ejection Fraction
Impulse Dynamics (USA) Inc. · Recruiting · NCT05064709 - Dapagliflozin in Acute Decompensated Heart Failure
AstraZeneca Pharmaceuticals LP
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.